News Home Page
Access the 15 most recent news items below. For older items, please click the 'view archives' link in the lower right.
Preliminary Study Finds Ebola Virus Fragments Can Persist in the Semen of Some Survivors for at Least Nine Months
Preliminary Study Finds Ebola Virus Fragments Can Persist in the Semen of Some Survivors for at Least Nine MonthsPreliminary results of a study into persistence of Ebola virus in body fluids show that some men still produce semen samples that test positive for Ebola virus nine months after onset of symptoms.The report, published today in the New England Journal of Medicine, provides the first results of a long-term study being jointly conducted by the Sierra Leone Ministry of Health and Sanitation, Sierra ...
Posted on: November 27, 2015
OncoQR's Breast Cancer Vaccine Successfully Completes Pre-Clinical Proof-of-Concept Study
OncoQR ML, a company developing Adjustable Cancer Immunotherapies, recently announced that its breast cancer vaccine candidate OQR200 has successfully completed a proof-of-concept study in non-human primates (NHPs). In the study, the vaccine elicited the expression of very high levels of polyclonal antibodies targeting multiple epitopes on Her2/neu. These epitopes include those two which are recognized by current blockbuster monoclonal antibodies Herceptin and Perjeta and which lead to ADCC (antibody ...
Posted on: November 26, 2015
BCSI Announces Breakthrough System That Improves IVF First-Cycle, Live-Birth Outcomes
Chances of a successful live birth after just one in-vitro fertilization (IVF) procedure are being improved thanks to a new laboratory instrument announced today by Blood Cell Storage Inc. (BCSI).BCSI's product, SAFE Sens TrakStation(TM), available this quarter, applies a best-practices approach based on pH monitoring during the initial five days of the in vitro fertilization process. The monitoring of pH is considered the best predictor of an IVF-induced live birth by leading embryologists including Dr. ...
Posted on: November 25, 2015
Study of GenomeDx's Decipher Prostate Cancer Test Selected as Best of ASTRO 2015
GenomeDx Biosciences recently announced that validation data for its Decipher Prostate Cancer Classifier, a genomic test for prostate cancer, will be presented next week at the American Society for Therapeutic Radiology and Oncology (ASTRO) Annual Meeting in San Antonio, Texas. The abstract was also selected for the 2015 Best of ASTRO, a two-day meeting in November providing a review of the most relevant, highly-rated abstracts from the 2015 ASTRO Annual Meeting.The abstract, titled "Validation of a ...
Posted on: November 24, 2015
Reimagine Launches #MoreThan Viral Campaign and Clinically-Proven Core Program to Help Millions Who Have Been Touched By Cancer
Reimagine, the most helpful collection of resources for those touched by cancer, is excited to announce their #MoreThan Campaign and the launch of the unique Core Program! Millions who have been touched by cancer are the heart of the #MoreThan Viral Campaign and Reimagine is asking the community to help spread the word starting today, Tuesday, October 13th and will run for 8 weeks till November 30th. The campaign kick starts across all Reimagine social media outlets including Facebook, Twitter and ...
Posted on: November 23, 2015
Purdue Makes Major New Investments in the Life Sciences
Purdue University recently announced plans to establish a new Pillars of Excellence in the Life Sciences Initiative aimed at enhancing Purdue's life sciences research and graduate education. The initiative comes as part of Purdue's recently announced $2 billion "Ever True" capital campaign.The investment will result in cohesive efforts across several colleges and is designed to produce preeminent contributions in the areas of integrative neurosciences and inflammation and immunology and infectious ...
Posted on: November 20, 2015
GCxGC-MS Validated for Metabolomics Profiling, Biomarker Discovery
Scientists at the David H. Murdock Research Institute (DHMRI), located at the NC Research Campus in Kannapolis, NC, validated the use of comprehensive two-dimensional gas chromatography mass spectrometry (GC×GC-MS) for metabolite biomarker discovery."GC x GC-MS is an approach to biomarker research that tends to be under-used," commented Kevin Knagge, PhD, group leader of the DHMRI Analytical Sciences Laboratory (ASL), which includes metabolomics, NMR and proteomics. "The advantage we found is that it ...
Posted on: November 19, 2015
Gyros Introduces Series of Kits for Bioprocess Analysis
Gyros AB, a pioneer in miniaturizing and automating immunoassays at nanoliter-scale, today introduced a series of new kits for analysis in bioprocess workflows. The new kits comprise Gyrolab™ CHO-HCP Kits 2-5 and two Gyrolab Human IgG Titer Kits for rapid quantification of IgG. Combined with the automation and high throughput of Gyrolab systems, GyrolabxP workstation and Gyrolab xPlore™, these kits facilitate increased productivity in process development and release testing.The four new ...
Posted on: November 18, 2015
Gensignia Receives CLIA Certification of Its San Diego Laboratory
Gensignia Life Sciences, Inc. (Gensignia) recently announced that it received certification under the Clinical Laboratory Improvement Amendments (CLIA). The State of California has granted the company initial CLIA clinical laboratory license under the "deemed status" provision of the U.S. Department of Health and Human Services (HHS) Center for Medicare and Medicaid Services (CMS)."With CLIA certification we have successfully executed on our plan to establish a clinical laboratory in San Diego for the ...
Posted on: November 17, 2015
Frost & Sullivan Names hc1.com the Best Healthcare CRM for Diagnostic Labs
Based on its recent analysis of the use of customer relationship management (CRM) solutions in the $70 billion US diagnostic laboratory market, Frost & Sullivan recognizes hc1.com with its 2015 North American Award for Product Leadership. Since its inception in 2011, hc1.com has become the world's most widely connected healthcare relationship management platform in the diagnostic laboratory market. The company's Healthcare Relationship Cloud® platform is the only solution built from the ground up ...
Posted on: November 16, 2015
Cancer Survivors Often Have Poor Diets, Which Can Affect their Long-Term Health
While most cancer survivors in the United States are motivated to seek information about food choices and dietary changes to improve their health, a new study comparing their dietary patterns to federal guidelines indicates that they often fall short. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings point to the need for dietary interventions in this vulnerable population.Cancer survivors have significantly elevated risks of a variety of health ...
Posted on: November 13, 2015
FDA Allows Marketing of the First Nucleic Acid-Based Test to Detect Multiple Pathogens from a Single Sample of Cerebrospinal Fluid
The FilmArray Meningitis/Encephalitis (ME) Panel uses CSF specimens from patients who have signs and/or symptoms of meningitis or encephalitis. It is intended as an aid in the diagnosis of those diseases when used in conjunction with other clinical and laboratory findings. October 8, 2015The U.S. Food and Drug Administration today allowed marketing of the first cerebrospinal fluid (CSF) nucleic acid-based test for simultaneous detection of multiple pathogens that can cause central nervous system ...
Posted on: November 12, 2015
VolitionRx Announces Publication of Results from Pancreatic Cancer Study with Lund University in Clinical Epigenetics
VolitionRx Limited (NYSE MKT: VNRX) recently announced that full results from a completed clinical study of its NuQ blood-based test for early stage pancreatic cancers have been published in the online issue of Clinical Epigenetics, the official journal of the Clinical Epigenetics Society. The peer-reviewed study was conducted in collaboration with Lund University, Sweden and led by Roland Andersson, MD, PhD, Professor of Surgery and Vice-Dean, Faculty of Medicine.The study assessed blood samples from 59 ...
Posted on: November 11, 2015
iSpecimen and the DHIN Announce Novel Program to Support Medical Research
iSpecimen, a trusted source of customized human biospecimen collections, and the Delaware Health Information Network (DHIN), the nation's first operational statewide health information exchange (HIE), recently announced a novel collaboration to support medical research. The joint program allows hospitals and labs in the DHIN network to easily repurpose remnant clinical specimens - samples that would otherwise be discarded once patient testing is complete - into medical research programs, while reducing ...
Posted on: November 10, 2015
Quest Diagnostics Introduces Complementary Diagnostic Test to Support Therapy for Non-squamous Non-small Cell Lung Cancer
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, recently announced that it now provides clinical laboratory testing using the PD-L1 IHC 28-8 pharmDx immunohistochemistry test, available through Dako, an Agilent Technologies company.The U.S. Food and Drug Administration (FDA) approved Bristol-Myers Squibb's OPDIVO (nivolumab) for the treatment of patients with previously treated metastatic non-small cell lung cancer (NSCLC). The approval expands the ...
Posted on: November 09, 2015